Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression

Journal of Immunology

Volumn 162, Issue 10, 1999, Pages 6162-6170

  Yoshikawa, Hideshi ^a   Nakajima, Yasuo ^a   Tasaka, Kachio ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 3; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA;

ALLERGIC REACTION; ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL AGGREGATION; CELL SURVIVAL; CROSS LINKING; CYTOKINE PRODUCTION; GENE EXPRESSION; INFLAMMATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; AUTOCRINE COMMUNICATION; CELL SURVIVAL; DEXAMETHASONE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOLOGIC CAPPING; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-3; INTERLEUKIN-4; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MAST CELLS; MICE; RECEPTORS, IGE;

EID: 0033563094     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Brown, M. A., J. H. Pierce, C. J. Watson, J. Falco, J. N. Ihle, and W. E. Paul. 1987. B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 50:809.
2. Burd, P. R., H. W. Rogers, J. R. Gordon, C. A. Martin, S. Jayaraman, S. D. Wilson, A. M. Dvorak, and M. E. Dorf. 1989. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170:245.
3. Plaut, M., J. H. Pierce, C. J. Watson, J. Hanley-Hyde, R. P. Nordan, and W. E. Paul. 1989. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or calcium ionophores. Nature 339:64.
4. Wodnar-Filipowicz, A., C. H. Heusser, and C. Moroni. 1989. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 339:150.
5. Gordon, J. R., and S. J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346:274.
6. Burd, P. R., W. C. Thompson, E. E. Max, and F. C. Mills. 1995. Activated mast cells produce interleukin 13. J. Exp. Med. 181:1373.
7. Durham, S. R., and A. B. Kay. 1985. Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions. Clin. Allergy 15:411.
8. Lee, F., T. Yokota, T. Otsuka, P. Meyerson, D. Villaret, R. Coffman, T. Mossman, D. Rennick, N. Roehm, C. Smith, et al. 1986. Isolation and characterization of a mouse interleukin cDNA clone that express B cell stimulatory factor 1 activities and T-cell- and mast cell-stimulating activities. Proc. Natl. Acad, Sci. USA 83:2061.
9. Tsuji, K., T. Nakahata, M. Takagi, T. Kobayashi, A. Ishiguro, K. Kikuchi, K. Naganuma, K. Koike, A. Miyajima, K. I. Arai, and T. Akabane. 1990. Effects of interleukin-3 and interleukin-4 on the development of "connective tissue-type" mast cells: interleukin-3 supports their survival and interleukin-4 triggers and supports their proliferation synergistically with interleukin-3. Blood 75:421.
10. Kay, A. B., S. Ying, V. Varney, M. Gaga, S. R. Durham, R. Moqbel, A. J. Wardlaw, and Q. Hamid. 1991. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Exp. Med. 173:775.
11. + T cells from allergen individuals. J. Exp. Med 178:2123.
12. + T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 181:1081.
13. Leung, D. Y. M., R. J. Martin, S. J. Szefler, E. R. Sher, S. Ying, A. B. Kay, and Q. Hamid. 1995. Dysregulation of interleukin 4, interleukin 5, and interferon γ gene expression in steroid-resistant asthma. J. Exp. Med. 181:33.
14. Madden, K. B., J. F. Urban, H. J. Ziltener, J. W. Schrader, F. D. Finkelman, and I. M. Katona. 1991 Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J. Immunol. 47:11387.
15. Finkelman, F. D., I. M. Katona, J. F. Urban, C. M. Snapper, J. Ohara, and W. E. Paul. 1986. Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine BSF-1. Proc. Natl. Acad. Sci. USA 83:9675.
16. Kühn, R., K. Rajewsky, and W. Müller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707.
17. Vajdy, M., M. H. Kosco-Vilbois, M. Kopf, G. Köhler, and N. Lycke. 1995. Impaired mucosal immune responses in interleukin 4-targeted mice. J. Exp. Med. 181:41.
18. Tepper, R. I., D. A. Levinson, B. Z. Stanger, J. Campos-Torres, A. K. Abbas, and P. Leder. 1990. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 62:457.
19. Le Gros, G., S. Z. Ben-Sasson, R. Seder, F. D. Finkelman, and W. E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:921.
20. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of TH2-like helper effectors. J. Immunol. 145:3796.
21. Bradding, P., I. H. Feather, P. H. Howarth, R. Mueller, J. A. Roberts, K. Britten, J. P. A. Bews, T. C. Hunt, Y. Okayama, C. H. Heusser, et al. 1992. Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176:1381.
22. Ben-Sasson, S. Z., G. Le Gros, D. H. Conrad, F. D. Finkelman, and W. E. Paul. 1990. Cross-linking Fc receptors stimulates splenic non-B, non-T cells to secrete interleukin 4 and other lymphokines. Proc. Natl. Acad. Sci. USA 87:1421.
23. Piccinni, M. P., D. Macchia, P. Parronchi, M. G. Giudizi, D. Bani, R. Alerini, A. Grossi, M. Ricci, E. Maggi, and S. Romagnani. 1991. Human bone-marrow non B, non T-cells produce interleukin 4 in response to cross-linkage of Fcε and Fcγ receptors. Proc. Natl. Acad. Sci. USA 88:8656.
24. Yoshikawa, H., T. Sakihama, Y. Nakajima, and K. Tasaka. 1996. Costimulation of fibronectin receptor promotes FcγR-mediated rescue of IL-3-dependent bone marrow-derived cells from apoptosis. J. Immunol. 156:1832.
25. Smith, T. J., L. A. Ducharme, and J. H. Weis. 1994. Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3. Eur. J. Immunol. 24:822.
26. Takagi, M., T. Nakahata, T. Kubo, M. Shiohara, K. Koike, A. Miyajima, K. I. Arai, S. I. Nishikawa, K. M. Zsebo, and A. Komiyama. 1992. Stimulation of mouse connective tissue-type mast cells by hemopoietic stem cell factor, a ligand for the c-kit receptor. J. Immunol. 148:3446.
27. Tagaya, Y., J. D. Burton, Y. Miyamoto, and T. A. Waldmann. 1996. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J. 15:4928.
28. Thompson-Snipes, L., V. Dhar, M. W. Bond, T. R. Mosmann, K. W. Moore, and D. M. Rennick. 1991. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med 173:507.
29. Lantz, C. S., J. Boesiger, C. H. Song, N. Mach, T. Kobayashi, R. C. Mulligan, Y. Nawa, G. Dranoff, and S. J. Galli. 1998. Role for interleukin-3 in mast cell and basophil development and in immunity to parasites. Nature 392:90.
30. Rousset, F., M. Billaud, D. Blanchard, C. Figdor, G. M. Lenoir, H. Spits, and J. E. De Vries. 1989. IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. J. Immunol. 143:1490.
31. Piela-Smith, T. H., G. Broketa, A. Hand, and J. H. Korn. 1992. Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4. J. Immunol. 148:1375.
32. Möst, J., W. Schwaeble, J. Drach, A. Sommerrauer, and M. P. Dierich. 1992. Regulation of the expression of ICAM-1 on human monocytes and monocytic tumor cell lines. J. Immunol. 148:1635.
33. Dastych, J., J. J. Costa, H. L. Thompson, and D. D. Metcalfe. 1991. Mast cell adhesion to fibronectin. Immunology 73:478.
34. Hamawy, M. M., S. E. Mergenhagen, and R. P. Siraganian. 1994. Adhesion molecules as regulators of mast-cell and basophil function. Immunol. Today 15:62.
35. 1, integrin genes by rodent mast cells. J. Immunol. 149:1964.
36. Ducharme, L. A., and J. H. Weis. 1992. Modulation of integrin expression during mast cell differentiation. Eur. J. Immunol. 22:2603.
37. Valent, P., D. Bevec, D. Maurer, J. Besemer, F. Di Padova, J. H. Butterfield, W. Speiser, O. Majdic, K. Lechner, and P. Bettelheim. 1991. Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Proc. Natl. Acad. Sci. USA 88:3339.
38. Bianchine, P. J., P. R. Burd, and D. D. Metcalfe. 1992. IL-3-dependent mast cells attach to plate-bound vitronectin: demonstration of augmented proliferation in response to signals transduced via cell surface vitronectin receptors. J. Immunol. 149:3665.
39. Walsh, L. J., G. Trinchieri, H. A. Waldorf, D. Whitaker, and G. F. Murphy. 1991. Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA 88:4220.
40. Thompson, H. L., P. D. Burbelo, Y. Yamada, H. K. Kleinman, and D. D. Metcalfe. 1989. Mast cells chemotax to laminin with enhancement after IgE-mediated activation. J. Immunol. 143:4188.
41. Hano, T., T. Kinashi, C. Ra, S. Nonoyama, J. I. Yata, and T. Nakahata. 1997. Interleukin-4 induces homotypic aggregation of human mast cells by promoting LFA-1/ICAM-1 adhesion molecules. Blood 89:3296.
42. Nieto, M. A., A. González, F. Gambón, F. Díaz-Espada, and A. López-Rivas. 1992. Apoptosis in human thymocytes after treatment with glucocorticoids. Clin. Exp. Immunol. 88:341.
43. Boumpas, D. T., E. D. Anastassiou, S. A. Older, G. C. Tsokos, D. L. Nelson, and J. E. Balow. 1991. Dexamethazone inhibits human IL-2 but not IL-2 receptor gene expression in vitro at the level of nuclear transcription. J. Clin. Invest. 87:1739.
44. Paliogianni, F., A. Raptis, S. S. Ahuja, S. M. Najjar, and D. T. Boumpas. 1993. Negative transcriptional regulation of the human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear factors AP-1 and NF-AT. J. Clin. Invest. 91:1481.
45. Arya, S. K., F. Wong-Stal, and R. C. Gallo. 1984. Dexamethazone-mediated inhibition of human T cell growth factor and γ-interferon messenger RNA. J. Immunol. 133:273.
46. Wu, C. Y., C. Fargeas, T. Nakajima, and G. Delespesse. 1991. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes. Eur. J. Immunol. 21:2645.
47. Kunicka, J. E., M. A. Talle, G. H. Denhardt, M. Brown, L. A. Prince, and G. Goldstein. 1993. Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethazone. Cell. Immunol. 149:39.
48. Robin, J.-L., D. C. Seldin, K. F. Austen, and R. A. Lewis. 1985. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. J. Immunol. 135:2719.
49. Eklund, K. K., D. E. Humphries, Z. Xia, N. Ghildyal, D. S. Friend, V. Gross, and R. L. Stevens. 1997. Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-α, and the IL-10-induced expression of chymases. J. Immunol. 158:4373.
50. Mekori, Y. A., C. K. Oh, and D. D. Metcalfe. 1993. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3: prevention of apoptosis by c-kit ligand. J. Immunol. 151:3775.
51. Wershil, B. K., G. T. Furuta, J. A. Lavigne, A. R. Choudhury, Z.-S. Wang, and S. J. Galli. 1995. Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades: multiple mechanismus of inhibition of IgE-and mast cell-dependent cutaneous inflammation in the mouse. J. Immunol. 154:1391.
52. Schmidt-Choudhury, A., G. T. Furuta, J. A. Lavigne, S. J. Galli, and B. K. Wershil. 1996. The regulation of tumor necrosis factor-α production in murine mast cells: pentoxifylline or dexamethazone inhibits IgE-dependent production of TNF-α by distinct mechanisms. Cell. Immunol. 171:140.
53. Henkel, G., and M. A. Brown. 1994. PU. 1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer. Proc. Natl. Acad. Sci. USA 91:7737.
54. Cronstein, B. N., S. Kimmel, R. I. Levin, F. Martiniuk, and G. Weissmann. 1992. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 89:9991.
55. Bradding, P., I. H. Feather, S. Wilson, P. G. Bardin, C. H. Heusser, S. T. Holgate, and P. H. Howarth. 1993. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. J. Immunol. 151:3853.
56. Ying, S., S. R. Durham, M. R. Jacobson, S. Rak, K. Masuyama, O. Lowhagen, A. B. Kay, and Q. A. Hamid. 1994. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 82:200.
57. Yoshikawa, H., T. Sakihama, Y. Nakajima, and K. Tasaka. 1997. FcγRIII-mediated regulation of hematopoiesis in murine bone marrow cells by interleukin-3 and CD95 (Fas/Apo-1). Blood 90:1911.
58. Dhein, J., H. Walczak, C. Baumler, K. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438.
59. Ligumsky, M., V. Kuperstein, H. Nechushtan, Z. Zhang, and E. Razin. 1997. Analysis of cytokine profile in human colonic mucosal FcεRI-positive cells by single cell PCR: inhibition of IL-3 expression in steroid-treated IBD patients. FEBS Lett. 413:436.
60. Finotto, S., Y. A. Mekori, and D. D. Metcalfe. 1997. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells. J. Clin. Invest. 99:1721.